NDC Compounded Drug 67157-002-15 Alpha Lipoic Acid
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Alpha Lipoic Acid
NDC crossover of Alpha Lipoic Acid with NDC 67157-002 a human compounded drug with other similar products matching the same substance name (Alpha Lipoic Acid) and the same administration route (intravenous) or dosage form (injection).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 26436-5027-2 | Alpha Lipoic Acid | Alpha Lipoic Acid 25mg/ml | 20 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
| 26436-5027-2 | Alpha Lipoic Acid | Alpha Lipoic Acid 25mg/ml | 20 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
| 26436-5027-2 | Alpha Lipoic Acid | Alpha Lipoic Acid 25mg/ml | 20 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
| 26436-5027-2 | Alpha Lipoic Acid | Alpha Lipoic Acid 25mg/ml | 20 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
Frequently Asked Questions
What is the NDC number assigned to Alpha Lipoic Acid?
Alpha Lipoic Acid was assigned by its manufacturer with NDC product code 67157-002. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Alpha Lipoic Acid?
The NDC package code 67157-002-15 was assigned to a 1 mL in 1 VIAL of alpha lipoic acid administered intravenous via injection.
Who manufactures this product?
Alpha Lipoic Acid is manufactured by an outsourced facility and labeled by Mcguff Outsourcing Solutions. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 4 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma with NDC product codes 26436-5027-2, 26436-5027-2, 26436-5027-2 and 26436-5027-2.